Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
obesity trial: cardiometabolic markers, liver fat reduction, lipid profiles Hepatology (2024) Triple agonists in NAFLD/NASH: hepatic steatosis resolution (preclinical and clinical evidence) The Lancet (2023) Supplementary Data Rosenstock et al
eLife 8 , e51601 (2019)
17298-37-2 Drug Class Breast Feeding Lactation Milk, Human Complementary Therapies Disclaimer: Information presented in this database is not meant as a substitute for professional judgment
Alternative Names: GRF 1-29, GHRH (1-29) amide
Internal Linking & Primary Citations Primary Source Citation: Canham, Neil
BPC-157 : TB500 (Thymosin Beta 4) : BPC-157 & TB500 (Thymosin Beta 4) CERTIFICATES OF ANALYSIS 6 COAs BN-25BT55-004 Current Variant: Size: 5mg-5mg BPC-157 TB-500 (TB4) 5.89 mg / 5.73 mg / 5.68 mg / 5.57 mg BN-25BT11-002 Current Variant: Size: 10mg-10mg BPC-157 10.86 mg / 10.89 mg TB-500 10.71 mg / 10.73 mg BN-26BT11-001 Upcoming Variant: Size: 10mg-10mg BPC-157 11.7 mg / 11.85 mg TB-500 11.54 mg / 11.44 mg BN-24BT55 Upcoming Variant: Size: 5mg-5mg BPC-157 5.57 mg TB-500 5.49 mg BN-25BT11-001 Previous Variant: Size: 10mg-10mg BN-24BT55-001 Previous Variant: 5 mg / 5 mg Formulation BPC-157 and TB-500 (Thymosin Beta-4) are research peptides supplied for use in controlled laboratory and analytical environments
